Clinical trial · Interventional
Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)
Study of Circulating Tumoral DNA Evolution in Plasma in Choroidal Melanoma
NCT02875652CI-TRIAL-00073495ctDNA MUcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Quantification and follow-up during 3 years of circulating tumoral DNA in patients with choroidal melanoma
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Choroidal Melanoma | Choroid Melanoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood sampling | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Blood sampling
- interventionNames
- Biological: Blood sampling
Primary outcomes (1)
- measure
- Assesment of the change of the circulating tumor DNA from baseline at 3 years
- timeFrame
- T0: before treatment; T1: 1 month after local treatment; T2: at 7 months; Tn : every 6 months up to 3 years.
Secondary outcomes (2)
- measure
- Compare the treatment effects of the primary tumor (protontherapy, iodine plaque, enucleation) on the rate of circulating tumoral DNA.
- timeFrame
- 3 years
- measure
- Comparison of the circulating tumor DNA rate to hepatic imaging if available.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Aged 18 years old or more. * Patient with a recent choroidal melanoma before the start of the specific treatment. * Patient able to stand a blood collection. * Work-up for extension (CT). * Patient explanation given and consent information signed or by legal representative Exclusion Criteria: * Patient without social protection / insurance. * Person deprived of liberty or under guardianship. * Inability to submit to medical monitoring of the trial for reasons of geography, social or psychological
References
Publications (0)
Data not yet available
No reference posted for this study.